PART I Overview Dyadic International, Inc. (Dyadic, we, us, our, or the Company), doing business as Dyadic Applied BioSolutions, is a global biotechnology company based in Jupiter, Florida, with operations in the United States and a satellite office in the Netherlands. The Company develops, manufactures, and commercializes precision-engineered, animal-free recombinant proteins and enzymes for applications in life sciences, food and nutrition, and bio-industrial markets. These products are produc...
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001493152-26-012672 | EDGAR | 55K words |
| 2025-03-26 | 2024-12-31 | 0001437749-25-009350 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001437749-24-009857 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001437749-23-008425 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001437749-22-007554 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001437749-21-007644 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001213809-20-000018 | EDGAR | — |
| 2019-03-27 | 2018-12-31 | 0001213809-19-000006 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001493152-25-021908 | EDGAR | 28K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023492 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001437749-25-016866 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001437749-24-034545 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001437749-24-026392 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001437749-24-016674 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001437749-23-030937 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001437749-23-022781 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001437749-23-013643 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001437749-22-026889 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001437749-22-019789 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001437749-22-012148 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001493152-26-013405 | EDGAR | 1K words |
| 2026-03-25 | 0001493152-26-012673 | EDGAR | — |
| 2026-03-06 | 0001493152-26-009179 | EDGAR | — |
| 2025-12-29 | 0001493152-25-029351 | EDGAR | — |
| 2025-12-29 | 0001493152-25-029141 | EDGAR | — |
| 2025-11-12 | 0001493152-25-021914 | EDGAR | — |
| 2025-10-07 | 0001493152-25-017306 | EDGAR | — |
| 2025-09-16 | 0001493152-25-013635 | EDGAR | — |
| 2025-08-13 | 0001641172-25-023496 | EDGAR | — |
| 2025-08-01 | 0001641172-25-021911 | EDGAR | — |
202 total filings indexed. 172 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001213809 |
| Ticker | DYAI |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.dyadic.com |
| Listed | 2004-11-05 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report